Terms: = Pancreatic cancer AND PR, PGR, progesterone receptor AND Staging
5 results:
1. Predictive value of computed tomography on surgical resectability in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: Results from a prospective, multicentre phase 2 trial (NEOLAP-AIO-PAK-0113).
Guggenberger KV; Bley TA; Held S; Keller R; Flemming S; Wiegering A; Germer CT; Kimmel B; Kunzmann V; Hartlapp I; Anger F
Eur J Radiol; 2023 Jun; 163():110834. PubMed ID: 37080059
[TBL] [Abstract] [Full Text] [Related]
2. Pyroptosis regulators exert crucial functions in prognosis, progression and immune microenvironment of pancreatic adenocarcinoma: a bioinformatic and in vitro research.
Bai Z; Xu F; Feng X; Wu Y; Lv J; Shi Y; Pei H
Bioengineered; 2022 Jan; 13(1):1717-1735. PubMed ID: 35000541
[TBL] [Abstract] [Full Text] [Related]
3. First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized pancreatic Ductal Adenocarcinoma.
Gulhati P; Prakash L; Katz MHG; Wang X; Javle M; Shroff R; Fogelman D; Lee JE; Tzeng CD; Lee JH; Weston B; Tamm E; Bhosale P; Koay EJ; Maitra A; Wang H; Wolff RA; Varadhachary GR
Ann Surg Oncol; 2019 Feb; 26(2):619-627. PubMed ID: 30324485
[TBL] [Abstract] [Full Text] [Related]
4. Safety and efficacy of single-day GemOx regimen in patients with pancreatobiliary cancer: a single institution experience.
Li J; Merl M; Lee MX; Kaley K; Saif MW
Expert Opin Drug Saf; 2010 Mar; 9(2):207-13. PubMed ID: 20095915
[TBL] [Abstract] [Full Text] [Related]
5. [Intra-arterial cisplatin and concurrent radiation for invasive bladder cancer].
Miyanaga N; Ohtani M; Noguchi R; Uchida K; Akaza H; Koiso K; Tatsuzaki H; Ohara K; Tsuji H; Inada T
Nihon Hinyokika Gakkai Zasshi; 1991 Oct; 82(10):1583-7. PubMed ID: 1770697
[TBL] [Abstract] [Full Text] [Related]
